The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Transdermal Drug Patches Market Research Report 2025

Global Transdermal Drug Patches Market Research Report 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1409419

No of Pages : 106

Ask Your Query
Synopsis
Transdermal Patch is a medicated adhesive patch that is placed on the skin to deliver a specific dose of medication through the skin and into the bloodstream. Transdermal Patches include fentanyl transdermal patch, nicotine transdermal patch, buprenorphine transdermal patch, clonidine transdermal patch, oxybutynin transdermal patch, estradiol transdermal patch, nitroglycerin transdermal patch and many others.
The global Transdermal Drug Patches market was valued at US$ 6831.1 million in 2023 and is anticipated to reach US$ 7641.6 million by 2030, witnessing a CAGR of 1.9% during the forecast period 2024-2030.
Global key players of transdermal drug patches include Hisamitsu Pharmaceutical, Johnson & Johnson, Mylan, UCB Pharma, Novartis, etc. The top five players hold a share about 37%. North America is the largest market, has a share about 50%, followed by Europe and Asia-Pacific, both have a share about 24 percent.
This report aims to provide a comprehensive presentation of the global market for Transdermal Drug Patches, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Transdermal Drug Patches.
Report Scope
The Transdermal Drug Patches market size, estimations, and forecasts are provided in terms of sales volume (M Pieces) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Transdermal Drug Patches market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Transdermal Drug Patches manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Hisamitsu Pharmaceutical
Johnson & Johnson
Mylan
UCB Pharma
Novartis
Teva Pharmaceutical
Beijing Tide Pharmaceutical
Chattem
Nitto Denko
Grünenthal
Mundipharma
GSK
Luye Pharma Group
Bayer
IBSA Group
Dr Reddy’s Laboratories
Segment by Type
Methyl Salicylate-based Patch
Rivastigmine Transdermal Patch
Fentanyl Transdermal Patch
Lidocaine Patch
Diclofenac Patch
Nicotine Transdermal Patch
Others
Segment by Application
Rx Channel
OTC Channel
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Transdermal Drug Patches manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Transdermal Drug Patches in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index
1 Transdermal Drug Patches Market Overview
1.1 Product Overview and Scope of Transdermal Drug Patches
1.2 Transdermal Drug Patches Segment by Type
1.2.1 Global Transdermal Drug Patches Market Value Comparison by Type (2024-2030)
1.2.2 Methyl Salicylate-based Patch
1.2.3 Rivastigmine Transdermal Patch
1.2.4 Fentanyl Transdermal Patch
1.2.5 Lidocaine Patch
1.2.6 Diclofenac Patch
1.2.7 Nicotine Transdermal Patch
1.2.8 Others
1.3 Transdermal Drug Patches Segment by Application
1.3.1 Global Transdermal Drug Patches Market Value by Application: (2024-2030)
1.3.2 Rx Channel
1.3.3 OTC Channel
1.4 Global Transdermal Drug Patches Market Size Estimates and Forecasts
1.4.1 Global Transdermal Drug Patches Revenue 2019-2030
1.4.2 Global Transdermal Drug Patches Sales 2019-2030
1.4.3 Global Transdermal Drug Patches Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Transdermal Drug Patches Market Competition by Manufacturers
2.1 Global Transdermal Drug Patches Sales Market Share by Manufacturers (2019-2024)
2.2 Global Transdermal Drug Patches Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Transdermal Drug Patches Average Price by Manufacturers (2019-2024)
2.4 Global Transdermal Drug Patches Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Transdermal Drug Patches, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Transdermal Drug Patches, Product Type & Application
2.7 Transdermal Drug Patches Market Competitive Situation and Trends
2.7.1 Transdermal Drug Patches Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Transdermal Drug Patches Players Market Share by Revenue
2.7.3 Global Transdermal Drug Patches Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Transdermal Drug Patches Retrospective Market Scenario by Region
3.1 Global Transdermal Drug Patches Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Transdermal Drug Patches Global Transdermal Drug Patches Sales by Region: 2019-2030
3.2.1 Global Transdermal Drug Patches Sales by Region: 2019-2024
3.2.2 Global Transdermal Drug Patches Sales by Region: 2025-2030
3.3 Global Transdermal Drug Patches Global Transdermal Drug Patches Revenue by Region: 2019-2030
3.3.1 Global Transdermal Drug Patches Revenue by Region: 2019-2024
3.3.2 Global Transdermal Drug Patches Revenue by Region: 2025-2030
3.4 North America Transdermal Drug Patches Market Facts & Figures by Country
3.4.1 North America Transdermal Drug Patches Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Transdermal Drug Patches Sales by Country (2019-2030)
3.4.3 North America Transdermal Drug Patches Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Transdermal Drug Patches Market Facts & Figures by Country
3.5.1 Europe Transdermal Drug Patches Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Transdermal Drug Patches Sales by Country (2019-2030)
3.5.3 Europe Transdermal Drug Patches Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Transdermal Drug Patches Market Facts & Figures by Country
3.6.1 Asia Pacific Transdermal Drug Patches Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Transdermal Drug Patches Sales by Country (2019-2030)
3.6.3 Asia Pacific Transdermal Drug Patches Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Transdermal Drug Patches Market Facts & Figures by Country
3.7.1 Latin America Transdermal Drug Patches Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Transdermal Drug Patches Sales by Country (2019-2030)
3.7.3 Latin America Transdermal Drug Patches Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Transdermal Drug Patches Market Facts & Figures by Country
3.8.1 Middle East and Africa Transdermal Drug Patches Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Transdermal Drug Patches Sales by Country (2019-2030)
3.8.3 Middle East and Africa Transdermal Drug Patches Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Transdermal Drug Patches Sales by Type (2019-2030)
4.1.1 Global Transdermal Drug Patches Sales by Type (2019-2024)
4.1.2 Global Transdermal Drug Patches Sales by Type (2025-2030)
4.1.3 Global Transdermal Drug Patches Sales Market Share by Type (2019-2030)
4.2 Global Transdermal Drug Patches Revenue by Type (2019-2030)
4.2.1 Global Transdermal Drug Patches Revenue by Type (2019-2024)
4.2.2 Global Transdermal Drug Patches Revenue by Type (2025-2030)
4.2.3 Global Transdermal Drug Patches Revenue Market Share by Type (2019-2030)
4.3 Global Transdermal Drug Patches Price by Type (2019-2030)
5 Segment by Application
5.1 Global Transdermal Drug Patches Sales by Application (2019-2030)
5.1.1 Global Transdermal Drug Patches Sales by Application (2019-2024)
5.1.2 Global Transdermal Drug Patches Sales by Application (2025-2030)
5.1.3 Global Transdermal Drug Patches Sales Market Share by Application (2019-2030)
5.2 Global Transdermal Drug Patches Revenue by Application (2019-2030)
5.2.1 Global Transdermal Drug Patches Revenue by Application (2019-2024)
5.2.2 Global Transdermal Drug Patches Revenue by Application (2025-2030)
5.2.3 Global Transdermal Drug Patches Revenue Market Share by Application (2019-2030)
5.3 Global Transdermal Drug Patches Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Hisamitsu Pharmaceutical
6.1.1 Hisamitsu Pharmaceutical Corporation Information
6.1.2 Hisamitsu Pharmaceutical Description and Business Overview
6.1.3 Hisamitsu Pharmaceutical Transdermal Drug Patches Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Hisamitsu Pharmaceutical Transdermal Drug Patches Product Portfolio
6.1.5 Hisamitsu Pharmaceutical Recent Developments/Updates
6.2 Johnson & Johnson
6.2.1 Johnson & Johnson Corporation Information
6.2.2 Johnson & Johnson Description and Business Overview
6.2.3 Johnson & Johnson Transdermal Drug Patches Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Johnson & Johnson Transdermal Drug Patches Product Portfolio
6.2.5 Johnson & Johnson Recent Developments/Updates
6.3 Mylan
6.3.1 Mylan Corporation Information
6.3.2 Mylan Description and Business Overview
6.3.3 Mylan Transdermal Drug Patches Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Mylan Transdermal Drug Patches Product Portfolio
6.3.5 Mylan Recent Developments/Updates
6.4 UCB Pharma
6.4.1 UCB Pharma Corporation Information
6.4.2 UCB Pharma Description and Business Overview
6.4.3 UCB Pharma Transdermal Drug Patches Sales, Revenue and Gross Margin (2019-2024)
6.4.4 UCB Pharma Transdermal Drug Patches Product Portfolio
6.4.5 UCB Pharma Recent Developments/Updates
6.5 Novartis
6.5.1 Novartis Corporation Information
6.5.2 Novartis Description and Business Overview
6.5.3 Novartis Transdermal Drug Patches Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Novartis Transdermal Drug Patches Product Portfolio
6.5.5 Novartis Recent Developments/Updates
6.6 Teva Pharmaceutical
6.6.1 Teva Pharmaceutical Corporation Information
6.6.2 Teva Pharmaceutical Description and Business Overview
6.6.3 Teva Pharmaceutical Transdermal Drug Patches Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Teva Pharmaceutical Transdermal Drug Patches Product Portfolio
6.6.5 Teva Pharmaceutical Recent Developments/Updates
6.7 Beijing Tide Pharmaceutical
6.6.1 Beijing Tide Pharmaceutical Corporation Information
6.6.2 Beijing Tide Pharmaceutical Description and Business Overview
6.6.3 Beijing Tide Pharmaceutical Transdermal Drug Patches Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Beijing Tide Pharmaceutical Transdermal Drug Patches Product Portfolio
6.7.5 Beijing Tide Pharmaceutical Recent Developments/Updates
6.8 Chattem
6.8.1 Chattem Corporation Information
6.8.2 Chattem Description and Business Overview
6.8.3 Chattem Transdermal Drug Patches Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Chattem Transdermal Drug Patches Product Portfolio
6.8.5 Chattem Recent Developments/Updates
6.9 Nitto Denko
6.9.1 Nitto Denko Corporation Information
6.9.2 Nitto Denko Description and Business Overview
6.9.3 Nitto Denko Transdermal Drug Patches Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Nitto Denko Transdermal Drug Patches Product Portfolio
6.9.5 Nitto Denko Recent Developments/Updates
6.10 Grünenthal
6.10.1 Grünenthal Corporation Information
6.10.2 Grünenthal Description and Business Overview
6.10.3 Grünenthal Transdermal Drug Patches Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Grünenthal Transdermal Drug Patches Product Portfolio
6.10.5 Grünenthal Recent Developments/Updates
6.11 Mundipharma
6.11.1 Mundipharma Corporation Information
6.11.2 Mundipharma Transdermal Drug Patches Description and Business Overview
6.11.3 Mundipharma Transdermal Drug Patches Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Mundipharma Transdermal Drug Patches Product Portfolio
6.11.5 Mundipharma Recent Developments/Updates
6.12 GSK
6.12.1 GSK Corporation Information
6.12.2 GSK Transdermal Drug Patches Description and Business Overview
6.12.3 GSK Transdermal Drug Patches Sales, Revenue and Gross Margin (2019-2024)
6.12.4 GSK Transdermal Drug Patches Product Portfolio
6.12.5 GSK Recent Developments/Updates
6.13 Luye Pharma Group
6.13.1 Luye Pharma Group Corporation Information
6.13.2 Luye Pharma Group Transdermal Drug Patches Description and Business Overview
6.13.3 Luye Pharma Group Transdermal Drug Patches Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Luye Pharma Group Transdermal Drug Patches Product Portfolio
6.13.5 Luye Pharma Group Recent Developments/Updates
6.14 Bayer
6.14.1 Bayer Corporation Information
6.14.2 Bayer Transdermal Drug Patches Description and Business Overview
6.14.3 Bayer Transdermal Drug Patches Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Bayer Transdermal Drug Patches Product Portfolio
6.14.5 Bayer Recent Developments/Updates
6.15 IBSA Group
6.15.1 IBSA Group Corporation Information
6.15.2 IBSA Group Transdermal Drug Patches Description and Business Overview
6.15.3 IBSA Group Transdermal Drug Patches Sales, Revenue and Gross Margin (2019-2024)
6.15.4 IBSA Group Transdermal Drug Patches Product Portfolio
6.15.5 IBSA Group Recent Developments/Updates
6.16 Dr Reddy’s Laboratories
6.16.1 Dr Reddy’s Laboratories Corporation Information
6.16.2 Dr Reddy’s Laboratories Transdermal Drug Patches Description and Business Overview
6.16.3 Dr Reddy’s Laboratories Transdermal Drug Patches Sales, Revenue and Gross Margin (2019-2024)
6.16.4 Dr Reddy’s Laboratories Transdermal Drug Patches Product Portfolio
6.16.5 Dr Reddy’s Laboratories Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Transdermal Drug Patches Industry Chain Analysis
7.2 Transdermal Drug Patches Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Transdermal Drug Patches Production Mode & Process
7.4 Transdermal Drug Patches Sales and Marketing
7.4.1 Transdermal Drug Patches Sales Channels
7.4.2 Transdermal Drug Patches Distributors
7.5 Transdermal Drug Patches Customers
8 Transdermal Drug Patches Market Dynamics
8.1 Transdermal Drug Patches Industry Trends
8.2 Transdermal Drug Patches Market Drivers
8.3 Transdermal Drug Patches Market Challenges
8.4 Transdermal Drug Patches Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock